Uipath Inc is a software-infrastructure business based in the US. Uipath shares (PATH) are listed on the NYSE and all prices are listed in US Dollars.
Our top pick for
Beginners
Our top pick for
Building a portfolio
Our top pick for
Active traders
| Latest market close | $20.55 |
|---|---|
| 52-week range | $13.66 - $69.60 |
| 50-day moving average | $18.23 |
| 200-day moving average | $35.04 |
| Wall St. target price | $29.60 |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-0.76 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $20.55 from 2022-07-05
| 1 week (2022-06-28) | 2.65% |
|---|---|
| 1 month (2022-06-03) | N/A |
| 3 months (2022-04-04) | -9.83% |
| 6 months (2022-01-07) | -47.58% |
| 1 year (2021-07-07) | -69.15% |
|---|---|
| 2 years (2020-07-03) | N/A |
| 3 years (2019-07-03) | N/A |
| 5 years (2017-07-03) | N/A |
Valuing Uipath stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Uipath's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Uipath's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 33.1886. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Uipath's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
However, it's sensible to consider Uipath's PEG ratio in relation to those of similar companies.
| Revenue TTM | $951.1 million |
|---|---|
| Gross profit TTM | $723.4 million |
| Return on assets TTM | -10.06% |
| Return on equity TTM | -21.61% |
| Profit margin | -42.95% |
| Book value | $3.45 |
| Market capitalisation | $10.2 billion |
TTM: trailing 12 months
We're not expecting Uipath to pay a dividend over the next 12 months.
You may also wish to consider:
UiPath Inc. provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, and Japan. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization. Its platform combines artificial intelligence with desktop recording, back-end mining of both human activity and system logs, and intuitive visualization tools, which enables users to discover, analyze, and identify processes to automate in a centralized portal; offers low-code development environments that allows users in an organization to create attended and unattended automations without any prior knowledge of coding; deploys robots in highly immersive attended experiences or in standalone, unattended modes behind the scenes, and can leverage native connectors built for commonly used line-of-business applications; offers centralized tools designed to manage, test, and deploy automations and ML models across the enterprise; allows customers to manage long running processes that orchestrate work between robots and humans; and enable users to track, measure, and forecast the performance of automation in their enterprise and help businesses ensure compliance with business standards. In addition, the company provides maintenance and support for its software, as well as professional services, such as training and implementation services to facilitate the adoption of its platform. It serves banking, healthcare, financial services, and government entities. UiPath Inc.
Everything we know about the Citrine Global IPO, plus information on how to buy in.
Everything we know about the Genelux Corporation IPO, plus information on how to buy in.
Everything we know about the Magic Empire Global IPO, plus information on how to buy in.
Everything we know about the Intchains Group IPO, plus information on how to buy in.
Everything we know about the Biostage IPO, plus information on how to buy in.
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
Everything we know about the OptMed IPO, plus information on how to buy in.
Everything we know about the Lichen China IPO, plus information on how to buy in.
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
Everything we know about the Nano Labs IPO, plus information on how to buy in.